New ray of hope for psychosis in parkinson’s: Pimavanserin.
Article
in English
| IMSEAR
| ID: sea-178264
ABSTRACT
Parkinson’s disease is often associated with hallucinations and psychosis. Till now typical and atypical antipsychotics (Clozapine & Quetiapine) are being used to manage these symptoms. Recently US FDA has approved a new drug Pimavanserin for the treatment of hallucination and delusion associated with parkinson’s disease psychosis in a dose of 34 mg.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Language:
English
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS